The purpose of this study is to investigate the pharmacokinetics of serum iron (the amount of iron in blood) after single oral administration of 2 tablets of L0008 80 mg (as ferrous sulphate) in women with iron deficiency anaemia.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
55
Oral administration (2 tablets)
Unnamed facility
Iași, Romania
Unnamed facility
Timișoara, Romania
Pharmacokinetic profile of serum iron after single oral administration of ferrous sulphate supplement
Pharmacokinetic profile of serum iron after single oral administration of ferrous sulphate supplement by measuring Maximum Plasma concentration, Time of Maximum Concentration, Area under the iron plasma concentration curve.
Time frame: Up to 24 hours
Tolerability of single administration (reported adverse events)
Tolerability by evaluating the number of subjects with emergent adverse events
Time frame: Up to 24 hours
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.